Preferred Label : thiazoles;

MeSH definition : Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms.;

MeSH synonym : Thiazole;

MeSH annotation : includes thiazolines, thiazolidines;

Is substance : O;

Details


Main resources

You can consult :

Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms.

https://ansm.sante.fr/informations-de-securite/piqray-r-alpelisib-deconditionnement-et-preparation-des-boites-de-50-200-mg-pour-prevenir-les-erreurs-medicamenteuses-liees-a-lindisponibilite-des-comprimes-doses-a-150-mg
2021
false
false
false
France
French
guidelines for drug use
medication errors
alpelisib
phosphatidylinositol 3-Kinases
Alpelisib/Fulvestrant Regimen
hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer
breast neoplasms
PIK3CA Gene Mutation
breast neoplasms
administration, oral
Alpelisib
Alpelisib
thiazoles
thiazoles
Phosphoinositide-3 Kinase Inhibitors
Phosphoinositide-3 Kinase Inhibitors

---
https://www.has-sante.fr/jcms/p_3234198/fr/doptelet
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
avatrombopag
avatrombopag
administration, oral
avatrombopag
adult
thrombocytopenia
receptors, thrombopoietin
blood loss, surgical
liver diseases
postoperative hemorrhage
chronic disease
Chronic Liver Disease
Product containing precisely avatrombopag (as avatrombopag maleate) 20 milligram/1 each conventional release oral tablet (clinical drug)
evaluation of the transparency committee
avatrombopag
avatrombopag
thiazoles
thiophenes
thiazoles
thiophenes

---
https://www.has-sante.fr/jcms/p_3233067/fr/piqray
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
administration, oral
alpelisib
Alpelisib/Fulvestrant Regimen
Fulvestrant
antineoplastic agents
antineoplastic agents
antineoplastic combined chemotherapy protocols
class I phosphatidylinositol 3-Kinases
PIK3CA Gene Mutation
breast neoplasms, male
breast neoplasms
postmenopause
hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer
evaluation of the transparency committee
Alpelisib
Alpelisib
thiazoles
thiazoles
Phosphoinositide-3 Kinase Inhibitors
Phosphoinositide-3 Kinase Inhibitors

---
https://ansm.sante.fr/tableau-marr/alpelisib
2021
false
false
false
France
French
guidelines for drug use
administration, oral
Drug-Related side effects and adverse reactions
alpelisib
Alpelisib
Alpelisib
continuity of patient care
Hyperglycaemic hyperosmolar nonketotic syndrome
hyperglycemia
ketosis
thiazoles
thiazoles

---
https://www.ema.europa.eu/en/medicines/human/EPAR/ponvory
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
ponesimod
ponesimod
drug approval
europe
ponesimod
Sphingosine 1 Phosphate Receptor Modulators
Sphingosine 1 Phosphate Receptor Modulators
multiple sclerosis, relapsing-remitting
adult
administration, oral
drug monitoring
aged
drug interactions
pregnancy
breast feeding
Female of Childbearing Potential
drug evaluation, preclinical
thiazoles
thiazoles

---
https://www.has-sante.fr/jcms/p_3284793/fr/ponvory-ponesimod
2021
false
false
false
France
evaluation of the transparency committee
thiazoles
thiazoles
treatment outcome
multiple sclerosis, relapsing-remitting
insurance, health, reimbursement
ponesimod
ponesimod
Sphingosine 1 Phosphate Receptor Modulators
Sphingosine 1 Phosphate Receptor Modulators
adult
ponesimod
administration, oral

---
https://www.ema.europa.eu/en/medicines/human/EPAR/piqray
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
alpelisib
antineoplastic agents
antineoplastic agents
breast neoplasms
postmenopause
antineoplastic combined chemotherapy protocols
hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer
mutation
PIK3CA Gene Mutation
administration, oral
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
contraception
class I phosphatidylinositol 3-Kinases
drug evaluation, preclinical
HR-positive, HER2-negative locally advanced breast cancer with PIK3CA mutation
Alpelisib/Fulvestrant Regimen
Alpelisib
Alpelisib
thiazoles
thiazoles
Phosphoinositide-3 Kinase Inhibitors
Phosphoinositide-3 Kinase Inhibitors

---
https://pharmactuel.com/index.php/pharmactuel/article/view/1261
2019
false
false
false
Canada
neoplasms
Factor Xa Inhibitors
edoxaban
critical appraisal or critical reading
comparative effectiveness research
dalteparin
anticoagulants
journal article
venous thromboembolism
edoxaban
pyridines
thiazoles

---
https://www.ema.europa.eu/en/medicines/human/EPAR/doptelet
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
avatrombopag
avatrombopag
avatrombopag
adult
thrombocytopenia
postoperative hemorrhage
administration, oral
receptors, thrombopoietin
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
blood loss, surgical
liver diseases
Chronic Liver Disease
Product containing precisely avatrombopag (as avatrombopag maleate) 20 milligram/1 each conventional release oral tablet (clinical drug)
avatrombopag
avatrombopag
thiazoles
thiophenes
thiazoles
thiophenes

---
https://ansm.sante.fr/informations-de-securite/Anticoagulants-Oraux-Directs-AODs-apixaban-Eliquis-R-rivaroxaban-Xarelto-R-dabigatran-Pradaxa-R-et-edoxaban-Lixiana-R-Roteas-R-non-recommandes-chez-les-patients-presentant-un-Syndrome-des-Antiphospholipides-SAPL
2019
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
administration, oral
apixaban
Rivaroxaban
edoxaban
anticoagulants
Dabigatran
recurrence
risk
antiphospholipid syndrome
thrombosis
thrombosis
pyrazoles
pyridones
pyridines
thiazoles

---
https://www.ema.europa.eu/en/medicines/human/EPAR/lusutrombopag-shionogi
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
lusutrombopag
lusutrombopag
adult
hemorrhage
thrombocytopenia
liver diseases
administration, oral
receptors, thrombopoietin
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
lusutrombopag
drug evaluation, preclinical
cinnamates
thiazoles
cinnamates
thiazoles

---
https://www.has-sante.fr/portail/jcms/c_2851086/fr/les-anticoagulants-oraux
2018
false
false
false
France
French
guidelines for drug use
anticoagulants
anticoagulants
administration, oral
antivitamins K
antivitamins K
atrial fibrillation
drug overdose
apixaban
Dabigatran
antithrombins
Factor Xa Inhibitors
Rivaroxaban
edoxaban
Direct factor Xa inhibitors
direct thrombin inhibitors
pregnancy
patient compliance
continuity of patient care
hemorrhage
surgical procedures, operative
blood loss, surgical
hemorrhage
vitamin k antagonists
fluindione
acenocoumarol
warfarin
pyridines
thiazoles
phenindione
phenindione
indenes
4-hydroxycoumarins
vitamin K
vitamin K
indenes
4-hydroxycoumarins
vitamin K
pyrazoles
pyridones

---
https://www.has-sante.fr/portail/jcms/c_2826827/fr/lixiana
2018
false
false
false
France
French
English
treatment outcome
edoxaban
Edoxaban Tosylate
administration, oral
stroke
embolism
adult
risk factors
atrial fibrillation
deep vein thrombosis
deep vein thrombosis
recurrence
pulmonary embolism
pulmonary embolism
hemorrhage
edoxaban
hemorrhage
Factor Xa Inhibitors
edoxaban
evaluation of the transparency committee
venous thrombosis
venous thrombosis
pyridines
thiazoles
pyridines
thiazoles

---
https://www.ema.europa.eu/medicines/human/EPAR/Masipro
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
masitinib
production
economics
thiazoles

---
https://www.has-sante.fr/portail/jcms/c_2801252/fr/betmiga-mirabegron-antispasmodique-urinaire
https://www.has-sante.fr/portail/jcms/c_2801252/fr/betmiga
2017
false
false
false
false
France
French
evaluation of the transparency committee
Delayed-Action preparations
administration, oral
treatment outcome
mirabegron
mirabegron
urological agents
urological agents
mirabegron
urinary incontinence
urinary incontinence, urge
urinary frequency
urinary bladder, overactive
adult
adrenergic beta-3 receptor agonists
adrenergic beta-3 receptor agonists
guidelines for drug use
insurance, health, reimbursement
acetanilides
thiazoles
acetanilides
thiazoles

---
https://www.has-sante.fr/portail/jcms/c_2788647/fr/atrican
2017
false
false
false
France
French
evaluation of the transparency committee
2-(alpha-thenoylamino)-2-nitro-5-thiazole
thiazoles

---
http://kce.fgov.be/fr/publication/report/anticoagulation-et-fibrillation-auriculaire
2017
false
false
false
Belgium
French
anticoagulants
anticoagulants
atrial fibrillation
treatment outcome
stroke
continuity of patient care
Cost-Benefit analysis
medication adherence
risk assessment
hemorrhage
vitamin K
antivitamins K
Rivaroxaban
edoxaban
Dabigatran
apixaban
Factor Xa Inhibitors
antithrombins
belgium
technical report
drug information
comparative study
anticoagulants
economic evaluation
drug monitoring
new oral anticoagulant
indenes
4-hydroxycoumarins
pyridines
thiazoles
pyrazoles
pyridones

---
https://vigilanses.mag.anses.fr/sites/default/files/VigilansesN1_m%C3%A9thylisothiasolinone_0.pdf
2017
false
false
false
France
French
journal article
2-methyl-4-isothiazolin-3-one
present
hypersensitivity
hypersensitivity reaction, nos
thiazoles

---
https://www.ema.europa.eu/medicines/human/EPAR/Roteas
2017
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
edoxaban
edoxaban
Edoxaban Tosylate
Edoxaban Tosylate
drug approval
europe
product surveillance, postmarketing
administration, oral
stroke
embolism
adult
risk factors
atrial fibrillation
deep vein thrombosis
deep vein thrombosis
recurrence
pulmonary embolism
pulmonary embolism
drug interactions
pregnancy
breast feeding
hemorrhage
Edoxaban Tosylate
hemorrhage
Factor Xa Inhibitors
Factor Xa Inhibitors
edoxaban
drug evaluation, preclinical
drug evaluation
venous thrombosis
venous thrombosis
pyridines
thiazoles
pyridines
thiazoles

---
https://www.revmed.ch/RMS/2016/RMS-N-542/Anticoagulants-oraux-directs-ACOD-une-aide-a-la-prescription-dans-la-pratique-quotidienne
2016
false
false
false
Switzerland
French
journal article
venous thromboembolism
antithrombins
administration, oral
atrial fibrillation
Evidence-Based medicine
guidelines for drug use
recurrence
venous thromboembolism
antithrombins
Direct factor Xa inhibitors
Factor Xa Inhibitors
Factor IIa
dabigatran etexilate
Dabigatran
Rivaroxaban
apixaban
edoxaban
drug interactions
continuity of patient care
clinical chemistry tests
kidney function tests
hemorrhage
surgical procedures, operative
heparin
antivitamins K
patient safety
factor IIa
prothrombin
pyrazoles
pyridones
pyridines
thiazoles
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
https://www.revmed.ch/RMS/2016/RMS-N-529/Anticoagulants-oraux-directs-quelques-considerations-pratiques
2016
false
false
false
Switzerland
French
journal article
administration, oral
anticoagulants
thromboembolism
thromboembolism
Direct factor Xa inhibitors
direct thrombin inhibitors
aged
neoplasms
liver cirrhosis
obesity
continuity of patient care
drug interactions
antidotes
stroke
treatment outcome
anticoagulants
Dabigatran
Rivaroxaban
apixaban
edoxaban
anticoagulants
Contraindications, Procedure
pyrazoles
pyridones
pyridines
thiazoles
Contraindications, Drug

---
http://www.has-sante.fr/portail/jcms/c_2658576/fr/lixiana-avc-fanv
http://www.has-sante.fr/portail/jcms/c_2658576/fr/lixiana-avc-fanv-edoxaban-anticoagulant-par-voie-orale
2016
false
false
false
France
French
evaluation of the transparency committee
administration, oral
edoxaban
edoxaban
Factor Xa Inhibitors
Factor Xa Inhibitors
risk factors
adult
embolism
treatment outcome
edoxaban
insurance, health, reimbursement
atrial fibrillation
aged
guidelines for drug use
stroke
pyridines
thiazoles
pyridines
thiazoles

---
http://www.has-sante.fr/portail/jcms/c_2658504/fr/lixiana-mtev
http://www.has-sante.fr/portail/jcms/c_2658504/fr/lixiana-mtev-edoxaban-anticoagulant-par-voie-orale
2016
false
false
false
France
French
evaluation of the transparency committee
deep vein thrombosis
deep vein thrombosis
recurrence
adult
administration, oral
pulmonary embolism
pulmonary embolism
edoxaban
edoxaban
edoxaban
treatment outcome
insurance, health, reimbursement
Factor Xa Inhibitors
Factor Xa Inhibitors
guidelines for drug use
venous thromboembolism
venous thrombosis
venous thrombosis
pyridines
thiazoles
pyridines
thiazoles

---
Health Canada informing Canadians of risks related to certain preservatives in cosmetic, non-prescription and natural health products
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58290a-fra.php
2016
false
false
false
Canada
French
English
vigilance note
2-methyl-4-isothiazolin-3-one
preservatives, pharmaceutical
5-chloro-2-methyl-4-isothiazolin-3-one
cosmetics
nonprescription drugs
natural products
biological products
thiazoles

---
https://www.anses.fr/fr/system/files/CONSO2014SA0186Ra.pdf
2016
false
false
false
false
France
French
technical report
thiazoles
preservatives, pharmaceutical
respiratory hypersensitivity
skin manifestations
2-methyl-4-isothiazolin-3-one

---
https://www.ema.europa.eu/medicines/human/EPAR/Lixiana
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
edoxaban
edoxaban
Edoxaban Tosylate
Edoxaban Tosylate
drug approval
europe
product surveillance, postmarketing
administration, oral
stroke
embolism
adult
risk factors
atrial fibrillation
deep vein thrombosis
deep vein thrombosis
recurrence
pulmonary embolism
pulmonary embolism
drug interactions
pregnancy
breast feeding
hemorrhage
edoxaban
Edoxaban Tosylate
hemorrhage
Factor Xa Inhibitors
Factor Xa Inhibitors
Factor Xa Inhibitors
edoxaban
drug evaluation, preclinical
venous thrombosis
venous thrombosis
pyridines
thiazoles
pyridines
thiazoles
pyridines
thiazoles

---
https://www.ema.europa.eu/medicines/human/EPAR/Masiviera
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
drug evaluation
production
masitinib
denied
economics
gait, nos
thiazoles

---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=1078716&nom=(Thiocyanatométhylthio)-2+benzo(D)+thiazole
Canada
toxicological data sheet
thiazoles

---
https://www.jle.com/fr/revues/medecine/met/e-docs/00/04/99/39/resume.phtml
2014
false
France
French
atrial fibrillation
anticoagulants
journal article
thrombosis
vitamin K
drug interactions
practice guideline
aged
risk assessment
apixaban
edoxaban
pyridines
thiazoles
pyrazoles
pyridones
antithrombins
anticoagulotherapy
Rivaroxaban
Dabigatran
antivitamins K
indenes
4-hydroxycoumarins

---
http://www.has-sante.fr/portail/jcms/c_1758554/fr/betmiga
2014
false
false
false
France
French
evaluation of the transparency committee
Delayed-Action preparations
administration, oral
treatment outcome
mirabegron
mirabegron
urological agents
urological agents
mirabegron
urinary incontinence
urinary incontinence, urge
urinary frequency
urinary bladder, overactive
adult
adrenergic beta-3 receptor agonists
adrenergic beta-3 receptor agonists
clinical trials as topic
guidelines for drug use
acetanilides
thiazoles
acetanilides
thiazoles

---
http://www.sciencedirect.com/science/article/pii/S0755498214002590
2014
false
false
false
France
French
atrial fibrillation
anticoagulants
administration, oral
anticoagulants
drug interactions
journal article
dabigatran etexilate
rivaroxaban
apixaban
apixaban
edoxaban
warfarin
factor xa
antithrombins
treatment outcome
renal insufficiency
age factors
Direct current cardioversion (procedure)
myocardial infarction
surgical procedures, operative
Factor Xa Inhibitors
anticoagulotherapy
Dabigatran
Rivaroxaban
pyridines
pyrazoles
pyridones
thiazoles

---
https://rmlg.uliege.be/article/2463
2013
false
true
false
Belgium
French
journal article
venous thromboembolism
venous thromboembolism
venous thromboembolism
hematologic agents
factor xa
thiazoles
pyridines
pyridines
pyridines
pyridines
thiazoles
thiazoles
thiazoles
venous thromboembolism
edoxaban
warfarin

---
http://www.lecrat.eu/?s=Meloxicam
2013
France
French
pregnancy
thiazines
thiazoles
cyclooxygenase inhibitors
anti-inflammatory agents, non-steroidal
meloxicam
thiazines
thiazines
thiazoles
thiazoles
drug information
Contraindications, Drug
Meloxicam

---
http://www.inrs.fr/accueil/produits/bdd/doc/fichetox.html?refINRS=FT%20290
2013
false
true
false
France
5-chloro-2-methyl-4-isothiazolin-3-one
thiazoles
2-methyl-4-isothiazolin-3-one
thiazoles
thiazoles
thiazoles
thiazoles
occupational exposure
toxicological data sheet

---
http://www.cochrane.org/fr/CD001945
http://www.cochrane.org/fr/CD006627
2013
France
United Kingdom
French
review of literature
meta-analysis
schizophrenia
mental disorders
antipsychotic agents
piperazines
thiazoles
treatment outcome

---
Summary Basis of Decision (SBD) for Myrbetriq
Mirabegron, 25 mg and 50 mg, tablets, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00230
2013
false
Canada
English
French
drug information
mirabegron
mirabegron
Mirabegron 25mg m/r tablet (product)
Mirabegron 50mg m/r tablet (product)
canada
drug approval
mirabegron
urinary bladder, overactive
adrenergic beta-3 receptor agonists
administration, oral
treatment outcome
controlled clinical trials as topic
adrenergic beta-3 receptor agonists
acetanilides
acetanilides
thiazoles
thiazoles

---
http://www.inrs.fr/accueil/produits/bdd/doc/fichetox.html?refINRS=FT%20243
France
French
thiazoles
thiazoles
thiazoles
thiazoles
thiazoles
occupational exposure
occupational diseases
reference values
1,2-benzisothiazoline-3-one
guidelines
toxicological data sheet

---
http://www.cochrane.org/fr/CD001924
2010
false
true
false
United Kingdom
France
lubeluzole
piperidines
thiazoles
treatment outcome
review of literature
french abstract
stroke
piperidines
thiazoles

---
https://www.ema.europa.eu/medicines/human/EPAR/Avandamet
2010
Non renseigné
French
English
syndication feed
diabetes mellitus, type 2
thiazoles
thiazoles
metformin
metformin
hypoglycemic agents
hypoglycemic agents
drug combinations
hypoglycemic agents
metformin
thiazoles
rosiglitazone-metformin combination
rosiglitazone-metformin combination
rosiglitazone-metformin combination
metformin and rosiglitazone
rosiglitazone-metformin combination
rosiglitazone maleate
drug evaluation
package leaflet
summary of product characteristics

---
https://www.cochrane.org/fr/CD007552/meloxicam-oral-en-dose-unique-pour-la-douleur-postoperatoire-aigue-chez-ladulte
2009
false
true
false
United Kingdom
France
thiazines
thiazoles
treatment outcome
review of literature
french abstract
adult
pain, postoperative
Meloxicam

---
Nous contacter.
05/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.